Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 9;24(1):510.
doi: 10.1186/s13063-023-07510-x.

A community-based intervention to improve screening, referral and follow-up of non-communicable diseases and anaemia amongst pregnant and postpartum women in rural India: study protocol for a cluster randomised trial

Jane Elizabeth Hirst  1   2 , Nicole Votruba  3   4 , Laurent Billot  5 , Varun Arora  6 , Eldho Rajan  7 , Sudhir Raj Thout  7 , David Peiris  8 , Anushka Patel  5 , Robyn Norton  4   5 , Edward Mullins  4 , Ankita Sharma  3 , Stephen Kennedy  3 , Vivekanand Jha  7   9   10 , Devarsetty Praveen  7   9   10
Affiliations

A community-based intervention to improve screening, referral and follow-up of non-communicable diseases and anaemia amongst pregnant and postpartum women in rural India: study protocol for a cluster randomised trial

Jane Elizabeth Hirst et al. Trials. .

Abstract

Background: Medical complications during pregnancy, including anaemia, gestational diabetes mellitus and hypertensive disorders of pregnancy place women are at higher risk of long-term complications. Scalable and low-cost strategies to integrate non-communicable disease screening into pregnancy care are needed. We aim to determine the effectiveness and implementation components of a community-based, digitally enabled approach, "SMARThealth Pregnancy," to improve health during pregnancy and the first year after birth.

Methods: A pragmatic, parallel-group, cluster randomised, type 2 hybrid effectiveness-implementation trial of a community-based, complex intervention in rural India to decrease anaemia (primary outcome, defined as haemoglobin < 12g/dL) and increase testing for haemoglobin, glucose and blood pressure (secondary outcomes) in the first year after birth. Primary Health Centres (PHCs) are the unit of randomisation. PHCs are eligible with (1) > 1 medical officer and > 2 community health workers; and (2) capability to administer intravenous iron sucrose. Thirty PHCs in Telangana and Haryana will be randomised 1:1 using a matched-pair design accounting for cluster size and distance from the regional centre. The intervention comprises (i) an education programme for community health workers and PHC doctors; (ii) the SMARThealth Pregnancy app for health workers to support community-based screening, referral and follow-up of high-risk cases; (iii) a dashboard for PHC doctors to monitor high-risk women in the community; (iv) supply chain monitoring for consumables and medications and (v) stakeholder engagement to co-develop implementation and sustainability pathways. The comparator is usual care with additional health worker education. Secondary outcomes include implementation outcomes assessed by the RE-AIM framework (reach, effectiveness, adoption, implementation, maintenance), clinical endpoints (anaemia, diabetes, hypertension), clinical service delivery indicators (quality of care score), mental health and lactation practice (PHQ9, GAD7, EuroQoL-5D, WHO IYCF questionnaire).

Discussion: Engaging women with screening after a high-risk pregnancy is a challenge and has been highlighted as a missed opportunity for the prevention of non-communicable diseases. The SMARThealth Pregnancy trial is powered for the primary outcome and will address gaps in the evidence around how pregnancy can be used as an opportunity to improve women's lifelong health. If successful, this approach could improve the health of women living in resource-limited settings around the world.

Trial registration: ClinicalTrials.gov NCT05752955. Date of registration 3 March 2023.

Keywords: Anaemia; Clinical decision support; Community health workers; Complex intervention; Gestational diabetes; Hybrid type-2 implementation; Maternal health; Non-communicable diseases; Preeclampsia; Rural India; mHealth.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Consort diagram
Fig. 2
Fig. 2
SHP intervention
See this image and copyright information in PMC

References

    1. Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO.
    1. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1084–150. - PMC - PubMed
    1. Mehran R, Vogel B, Ortega R, Cooney R, Horton R. The lancet commission on women and cardiovascular disease: time for a shift in women's health. Lancet. 2019;393(10175):967–968. doi: 10.1016/S0140-6736(19)30315-0. - DOI - PubMed
    1. Hirst JE, Nagraj S, Henry A, Mackillop L, Norton R, Kennedy S. The obstetrician's role in preventing cardiometabolic disease. Obstet Gynaecol. 2019;21(4):247–254. doi: 10.1111/tog.12600. - DOI
    1. Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2):e003497. doi: 10.1161/CIRCOUTCOMES.116.003497. - DOI - PubMed

Publication types

Associated data